Clinical Trial

Effects of Short-term Intensive Statin Therapy on Lipid Levels

Recruiting
View on ClinicalTrials.gov →
Summary
Acute cerebral infarction (ACI), often linked to arterial stenosis, is a major cause of death and disability. Statins are cornerstone therapies for secondary prevention, effectively lowering LDL-C and stabilizing plaques. However, patient response to intensive statin therapy varies significantly. This prospective study aims to analyze the short-term lipid-lowering effects and influencing factors of such therapy in ACI patients with stenosis, to guide personalized treatment and improve outcomes.
Trial Details
NCT Number NCT07344610
Lead Sponsor General Hospital of Shenyang Military Region
Conditions Ischemic Stroke
Enrollment 800 participants
Start Date 2026-01-08
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-15